Senate Revises Comparative Effectiveness Plan In Reform Bill
This article was originally published in The Tan Sheet
Executive Summary
Comparative effectiveness research that Senate Finance Committee Chairman Max Baucus envisioned - led by a non-government institute with funding from public and private sources - is among the health care reform provisions being debated
You may also be interested in...
Selling Comparative Effectiveness: Practice May Need Positive Branding
With the national infrastructure for comparative effectiveness research set to expand, federal agencies should be thinking about how to get out a positive message about the oft-maligned practice, policy experts say
Baucus Bill Takes “Patient-Centered” Focus For Comparative Effectiveness
The latest comparative effectiveness legislation from Sen. Max Baucus suggests an approach that might be more welcome to the pharma industry
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC